1-2 of 2
Michael Kluge
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions

Natalie Hartmann, Joanna J. Messmann, Frank Leithäuser, Maxi Weiswange, Michael Kluge, Harald Fricke, Klaus-Michael Debatin, Gudrun Strauss
Journal: Blood
Blood (2013) 121 (3): 556–565.
https://doi.org/10.1182/blood-2012-04-423392
Published: 2013
Includes: Supplemental data
Journal Articles

APG101 - a Novel Inhibitor of CD95/CD95L Signaling Prevents Graft-Versus-Host Disease without Disabling T Cell Effector Function and Anti-Tumor Activity,

Gudrun Strauss, PhD, Natalie Hartmann, PhD, Michael Kluge, PhD, Harald Fricke, MD, PhD, Klaus-Michael Debatin, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4019.
https://doi.org/10.1182/blood.V118.21.4019.4019
Published: 2011